Search

everythinglearnresearchcommunity

for

Search:↓

A 37-year-old man with hair loss and skin issues was successfully treated with oral antibiotics, highlighting the need for early treatment. Long-term care includes low-dose antibiotics and avoiding caps and wigs.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Transplant success has improved with better immunosuppressive drugs and donor matching.

One minoxidil-sensitive potassium channel exists in human hair follicles.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Shen-Min, a hair growth supplement, likely caused acute hepatitis in a woman, improving after she stopped taking it.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Researchers developed a method to grow hair follicles using special beads that could help with hair loss treatment.

Chemokine signaling is important for hair development.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

The conclusion is that exogen is a unique hair cycle phase and the new sampling method specifically targets this stage, which may help in future hair loss research.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The skin and thymus develop similarly to protect and support immunity.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.